THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans
Hydroxytyrosol in the prevention of the metabolic syndrome and related disorders
Once you start adding these up, its easy to see why 40% of you probably have some form of B12 deficiency
Similar to DBS, tDCS impacts the cerebellum, the thalamus, the basal ganglia, and the cortex, as measured by the cerebellar brain inhibition (CBI), EEG, and behavioral indices [201,203,204,204]
Recent advancements in the use of exosomes as drug delivery systems
Funding: Open Access publication was supported by an unrestricted donation from Pure Encapsulations, Sudbury, MA, USA